ProfileGDS4132 / 240756_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 27% 29% 31% 36% 25% 29% 32% 26% 32% 36% 39% 40% 30% 26% 40% 47% 32% 34% 40% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10166.588727
GSM201543Muscle PCOS pioglitazone 12162.881529
GSM201544Muscle PCOS pioglitazone 16179.308631
GSM201545Muscle PCOS pioglitazone 20198.15736
GSM201829Muscle PCOS pioglitazone 23164.446825
GSM201830Muscle PCOS pioglitazon 25172.990429
GSM201831Muscle PCOS pioglitazone 27176.89632
GSM201832Muscle PCOS pioglitazone 3162.127826
GSM201833Muscle PCOS pioglitazone 4174.701432
GSM201834Muscle PCOS pioglitazone 8188.053836
GSM201835Muscle PCOS after pioglitazone 10286.573239
GSM201836Muscle PCOS after pioglitazone 12292.261240
GSM201837Muscle PCOS after pioglitazone 16259.303530
GSM201838Muscle PCOS after pioglitazone 20255.26626
GSM201839Muscle PCOS after pioglitazone 23297.131440
GSM201840Muscle PCOS after pioglitazone 252119.75747
GSM201841Muscle PCOS after pioglitazone 27265.707232
GSM201842Muscle PCOS after pioglitazone 3268.235534
GSM201843Muscle PCOS after pioglitazone 42100.54140
GSM201844Muscle PCOS after pioglitazone 8283.884135